These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2114619)

  • 1. Comparisons of in vitro nitroglycerin (TNG) flux across yucatan pig, hairless mouse, and human skins.
    Roberts ME; Mueller KR
    Pharm Res; 1990 Jun; 7(6):673-6. PubMed ID: 2114619
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement.
    Higo N; Hinz RS; Lau DT; Benet LZ; Guy RH
    Pharm Res; 1992 Mar; 9(3):303-6. PubMed ID: 1614960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin.
    Higo N; Hinz RS; Lau DT; Benet LZ; Guy RH
    Pharm Res; 1992 Feb; 9(2):187-90. PubMed ID: 1553339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro.
    Kikkoji T; Gumbleton M; Higo N; Guy RH; Benet LZ
    Pharm Res; 1991 Oct; 8(10):1231-7. PubMed ID: 1796039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol: water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin.
    Berner B; Mazzenga GC; Otte JH; Steffens RJ; Juang RH; Ebert CD
    J Pharm Sci; 1989 May; 78(5):402-7. PubMed ID: 2501473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative controlled skin permeation of nitroglycerin from marketed transdermal delivery systems.
    Chien YW; Keshary PR; Huang YC; Sarpotdar PP
    J Pharm Sci; 1983 Aug; 72(8):968-70. PubMed ID: 6413678
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of Yucatan micropig skin for use as an in vitro model for skin permeation study.
    Fujii M; Yamanouchi S; Hori N; Iwanaga N; Kawaguchi N; Matsumoto M
    Biol Pharm Bull; 1997 Mar; 20(3):249-54. PubMed ID: 9084881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of vehicle additives on the transdermal delivery of nitroglycerin.
    Loftsson T; Gildersleeve N; Bodor N
    Pharm Res; 1987 Oct; 4(5):436-7. PubMed ID: 3150045
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal models for percutaneous absorption.
    Jung EC; Maibach HI
    J Appl Toxicol; 2015 Jan; 35(1):1-10. PubMed ID: 25345378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Comparison of Surface Free Energy of Human, Yucatan Micropig, and Hairless Mouse Skins and Influence of Surfactant on Surface Free Energy of the Skin.
    Fujii M; Kato K; Imai M; Kuwabara H; Awano M; Hashizaki K; Taguchi H
    Biol Pharm Bull; 2019 Feb; 42(2):295-298. PubMed ID: 30504641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro.
    Loftsson T; Somogyi G; Bodor N
    Acta Pharm Nord; 1989; 1(5):279-86. PubMed ID: 2514720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of hairless mouse as an experimental model of percutaneous penetration in man.
    Simon GA; Maibach HI
    Skin Pharmacol Appl Skin Physiol; 1998; 11(2):80-6. PubMed ID: 9603658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro permeation of some beta-blockers across the hairless mouse skin.
    Ghosh TK; Chiao CS; Gokhale RD
    J Pharm Pharmacol; 1993 Mar; 45(3):218-9. PubMed ID: 8097781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of various marine lipids on transdermal drug delivery--in vitro evaluation.
    Loftsson T; Gunnarsdóttir T; Magnúsdóttir LM; Frioriksdóttir H; Guomundsdóttir TK; Olafsson JH; Haraldsson GG; Guomundsson G; Hjaltason B
    Boll Chim Farm; 1997 Nov; 136(10):640-5. PubMed ID: 9528172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced delivery of mitomycin C derivatives through hairless mouse and rat skins.
    Hashida M; Mukai E; Kimura T; Sezaki H
    J Pharm Pharmacol; 1985 Aug; 37(8):542-4. PubMed ID: 2864413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of marigold extract-loaded formulations against UV-induced oxidative stress.
    Fonseca YM; Catini CD; Vicentini FT; Cardoso JC; Cavalcanti De Albuquerque Junior RL; Vieira Fonseca MJ
    J Pharm Sci; 2011 Jun; 100(6):2182-93. PubMed ID: 21491442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a monolithic drug-in-adhesive patch for valsartan.
    Nishida N; Taniyama K; Sawabe T; Manome Y
    Int J Pharm; 2010 Dec; 402(1-2):103-9. PubMed ID: 20933069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin.
    Bond JR; Barry BW
    J Invest Dermatol; 1988 Jun; 90(6):810-3. PubMed ID: 3373011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different membranes with cultures of keratinocytes from man for percutaneous absorption of nitroglycerine.
    Minghetti P; Casiraghi A; Cilurzo F; Montanari L; Marazzi M; Falcone L; Donati V
    J Pharm Pharmacol; 1999 Jun; 51(6):673-8. PubMed ID: 10454043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of 4-hydroxyanisole and all-trans retinoic acid produces synergistic skin depigmentation in swine.
    Nair X; Parab P; Suhr L; Tramposch KM
    J Invest Dermatol; 1993 Aug; 101(2):145-9. PubMed ID: 8345215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.